Search For "phase iii"
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
Updated : 5 years, 5 months ago IST
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Read More
70-80 pc reduction in COVAXIN trial participation: AIIMS doctor
Updated : 5 years, 5 months ago IST
New Delhi [India], December 16 (ANI): With the start of COVID vaccination an immediate future in India, the phase III clinical trial for indigenously-developed Bharat Biotech's vaccine candidate COVAXIN is witnessing a shortage of volunteer participation, with a high refusal rate 70 per c
Read More
Two weeks after getting first Covaxin trial shot in Haryana, Anil Vij test
Updated : 5 years, 5 months ago IST
New Delhi [India], December 5 (ANI): Haryana Home Minister Anil Vij, who received the first dose of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, during its Phase-III trial in the state two weeks ago, on Saturday said that he has tested positive for the virus.
Read More
Governor Jagdeep Dhankhar inaugurates Phase III trial of Covaxin in Kolkat
Updated : 5 years, 5 months ago IST
Kolkata (West Bengal) [India], December 2 (ANI): West Bengal Governor Jagdeep Dhankhar inaugurated the phase III regulatory trial of Bharat Biotech's coronavirus vaccine candidate Covaxin in Kolkata on Wednesday.
Read More
Anil Vij offers to be 'first volunteer' for Phase-III trial of Covaxin in
Updated : 5 years, 6 months ago IST
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
Read More
Bharat Biotech starts phase III trials for COVAXIN
Updated : 5 years, 6 months ago IST
Hyderabad [India], November 17, (ANI): Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.
Read More
COVISHIELD completes enrolment of Phase III clinical trials under ICMR, SI
Updated : 5 years, 6 months ago IST
New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have announced the completion of enrolment of phase 3 clinical trials for COVISHIELD in India.
Read More
Keeping Pfizer's COVID-19 vaccine at low temperatures will be challenging
Updated : 5 years, 6 months ago IST
New Delhi [India], November 11 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's COVID-19 vaccine phase III trials are very encouraging but preserving it at very low temperatures, -70 degree C, will
Read More
CCEA approves second, third phase of DRIP for improving 736 dams
Updated : 5 years, 6 months ago IST
New Delhi [India], October 29 (ANI): The Cabinet Committee on Economic Affairs (CCEA) on Thursday approved the Dam Rehabilitation and Improvement Project (DRIP) Phase II and Phase III to improve safety and operational performance of selected dams across the country.
Read More
DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19 vaccine
Updated : 5 years, 7 months ago IST
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Read More
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biote
Updated : 5 years, 7 months ago IST
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Read More
Submit previous trial data for Covaxin before rolling out phase III: Drug
Updated : 5 years, 7 months ago IST
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
Read More